Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease

Bateman RJ, Smith J, Donohue MC et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. PMID: 37966285

https://pubmed.ncbi.nlm.nih.gov/37966285/